Anti‑inflammatory effect of Resolvin D1 on LPS‑treated MG‑63 cells Corrigendum in /10.3892/etm.2019.8021

Cao,Dan; Pi,Jing; Shan,Yihong; Tang,Yuping; Zhou,Ping

doi:10.3892/etm.2018.6721

Anti‑inflammatory effect of Resolvin D1 on LPS‑treated MG‑63 cells

Corrigendum in: /10.3892/etm.2019.8021

Authors:
- Dan Cao
- Jing Pi
- Yihong Shan
- Yuping Tang
- Ping Zhou
View Affiliations

Affiliations: Department of Orthopedics, Children's Hospital of Nanjing Medical University, Nanjing, Jiangsu 210009, P.R. China
Published online on: September 11, 2018 https://doi.org/10.3892/etm.2018.6721
Pages: 4283-4288

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Inflammation reaction plays an important role in the pathogenesis of ankle fracture. The aim of the present study was to investigate the effect of RvD1 on the inflammatory response and underlying molecular mechanisms in MG‑63 cells. Reverse transcription‑quantitative polymerase chain reaction (RT‑qPCR) and ELISA were used to determine the mRNA and protein expression of cytokines extracted from peripheral blood in children with or without ankle fracture, respectively. MG‑63 cells were pre‑treated with/without RvD1 and stimulated with 1 µg/ml LPS. The cell viability was detected by MTT assay. The production of cytokines from MG‑63 cells was assessed by RT‑qPCR and western blot, respectively. The expression of p‑p38, NF‑κB (p50) and cyclooxygenase‑2 (COX‑2) mRNA and protein were detected by western blot and/or RT‑qPCR. The levels of NLRP3, associated recruitment domain (ASC), cleaved caspase1, caspase‑1 were measured by RT‑qPCR and/or western blot. The levels of interleukin (IL)‑1β, IL‑6 and tumor necrosis factor (TNF‑α) mRNA and protein were up‑regulated in children with ankle fracture compared with healthy children. RvD1 treatment did not induce cytotoxicity in MG‑63 cells, but it can inhibit LPS induced MG‑63 cell proliferation inhibition. RvD1 was able to dose‑dependently reverse LPS induced up‑regulation of TNF‑α, IL‑1β, IL‑6 mRNA and protein expression. Furthermore, the LPS induced up‑regulation of p‑p38, NF‑κB (p50), and NLRP3, ASC, cleaved caspase‑1/caspase‑1, and COX‑2 was dose‑dependently reversed by RvD1. In conclusion, The present study demonstrated that RvD1 inhibited inflammation though inhibiting MAPKp38/NF‑κB pathway and NLRP3 inflammasome expression in MG‑63 cells, indicating that it may be an effective drug for the treatment of ankle fracture.

View Figures

View References

1	MacIntyre NJ and Dewan N: Epidemiology of distal radius fractures and factors predicting risk and prognosis. J Hand Ther. 29:136–145. 2016. View Article : Google Scholar : PubMed/NCBI
2	Moon RJ, Harvey NC, Curtis EM, de Vries F, van Staa T and Cooper C: Ethnic and geographic variations in the epidemiology of childhood fractures in the United Kingdom. Bone. 85:9–14. 2016. View Article : Google Scholar : PubMed/NCBI
3	Hedstrom EM, Svensson O, Bergström U and Michno P: Epidemiology of fractures in children and adolescents. Acta Orthop. 81:148–153. 2010. View Article : Google Scholar : PubMed/NCBI
4	Chevalley T, Bonjour JP, van Rietbergen B, Rizzoli R and Ferrari S: Fractures in healthy females followed from childhood to early adulthood are associated with later menarcheal age and with impaired bone microstructure at peak bone mass. J Clin Endocrinol Metab. 97:4174–4181. 2012. View Article : Google Scholar : PubMed/NCBI
5	He Z, Selvamurugan N, Warshaw J and Partridge NC: Pulsed electromagnetic fields inhibit human osteoclast formation and gene expression via osteoblasts. Bone. 106:194–203. 2018. View Article : Google Scholar : PubMed/NCBI
6	Huang H, Zhao N, Xu X, Xu Y, Li S, Zhang J and Yang P: Dose-specific effects of tumor necrosis factor alpha on osteogenic differentiation of mesenchymal stem cells. Cell Prolif. 44:420–427. 2011. View Article : Google Scholar : PubMed/NCBI
7	Serhan CN, Hong S, Gronert K, Colgan SP, Devchand PR, Mirick G and Moussignac RL: Resolvins: A family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J Exp Med. 196:1025–1037. 2002. View Article : Google Scholar : PubMed/NCBI
8	Sun YP, Oh SF, Uddin J, Yang R, Gotlinger K, Campbell E, Colgan SP, Petasis NA and Serhan CN: Resolvin D1 and its aspirin-triggered 17R epimer. Stereochemical assignments, anti-inflammatory properties and enzymatic inactivation. J Biol Chem. 282:9323–9334. 2007. View Article : Google Scholar : PubMed/NCBI
9	Werners AH and Bryant CE: Pattern recognition receptors in equine endotoxaemia and sepsis. Equine Vet J. 44:490–498. 2009. View Article : Google Scholar
10	Mori MA, Bezy O and Kahn CR: Metabolic syndrome: Is Nlrp3 inflammasome a trigger or a target of insulin resistance? Circ Res. 108:1160–1162. 2011. View Article : Google Scholar : PubMed/NCBI
11	Duffield JS, Hong S, Vaidya VS, Lu Y, Fredman G, Serhan CN and Bonventre JV: Resolvin D series and protectin D1 mitigate acute kidney injury. J Immunol. 177:5902–5911. 2006. View Article : Google Scholar : PubMed/NCBI
12	Yin Y, Chen F, Wang W, Wang H and Zhang X: Resolvin D1 inhibits inflammatory response in STZ-induced diabetic retinopathy rats: Possible involvement of NLRP3 inflammasome and NF-κB signaling pathway. Mol Vis. 23:242–250. 2017.PubMed/NCBI
13	Xu J, Gao X, Yang C, Chen L and Chen Z: Resolvin D1 attenuates Mpp+-induced parkinson disease via inhibiting inflammation in PC12 Cells. Med Sci Monit. 23:2684–2691. 2017. View Article : Google Scholar : PubMed/NCBI
14	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
15	Adams SB, Leimer EM, Setton LA, Bell RD, Easley ME, Huebner JL, Stabler TV, Kraus VB, Olson SA and Nettles DL: Inflammatory microenvironment persists after bone healing in intra-articular ankle fractures. Foot Ankle Int. 38:479–484. 2017. View Article : Google Scholar : PubMed/NCBI
16	Liao Z, Dong J, Wu W, Yang T, Wang T, Guo L, Chen L, Xu D and Wen F: Resolvin D1 attenuates inflammation in lipopolysaccharide-induced acute lung injury through a process involving the PPARγ/NF-κB pathway. Respir Res. 13:1102012. View Article : Google Scholar : PubMed/NCBI
17	Strowig T, Henao-Mejia J, Elinav E and Flavell R: Inflammasomes in health and disease. Nature. 481:278–286. 2012. View Article : Google Scholar : PubMed/NCBI
18	Menzel CL, Sun Q, Loughran PA, Pape HC, Billiar TR and Scott MJ: Caspase-1 is hepatoprotective during trauma and hemorrhagic shock by reducing liver injury and inflammation. Mol Med. 17:1031–1038. 2011. View Article : Google Scholar : PubMed/NCBI
19	Li G, Chen Z, Bhat OM, Zhang Q, Abais-Battad JM, Conley SM, Ritter JK and Li PL: NLRP3 inflammasome as a novel target for docosahexaenoic acid metabolites to abrogate glomerular injury. J Lipid Res. 58:1080–1090. 2017. View Article : Google Scholar : PubMed/NCBI
20	Shao A, Wu H, Hong Y, Tu S, Sun X, Wu Q, Zhao Q, Zhang J and Sheng J: Hydrogen-rich saline attenuated subarachnoid hemorrhage-induced early brain injury in rats by suppressing inflammatory response: possible involvement of NF-κB pathway and NLRP3 inflammasome. Mol Neurobiol. 53:3462–3476. 2016. View Article : Google Scholar : PubMed/NCBI
21	Wang B, Gong X, Wan JY, Zhang L, Zhang Z, Li HZ and Min S: Resolvin D1 protects mice from LPS-induced acute lung injury. Pulm Pharmacol Ther. 24:434–441. 2011. View Article : Google Scholar : PubMed/NCBI
22	Colby JK, Abdulnour RE, Sham HP, Dalli J, Colas RA, Winkler JW, Hellmann J, Wong B, Cui Y, El-Chemaly S, et al: Resolvin D3 and aspirin-triggered resolvin D3 are protective for injured epithelia. Am J Pathol. 186:1801–1813. 2016. View Article : Google Scholar : PubMed/NCBI
23	Xu J, Duan X, Hu F, Poorun D, Liu X, Wang X, Zhang S, Gan L, He M, Zhu K, et al: Resolvin D1 attenuates imiquimod-induced mice psoriasiform dermatitis through MAPKs and NF-κB pathways. J Dermatol Sci. 89:127–135. 2018. View Article : Google Scholar : PubMed/NCBI
24	Zwipp H, Hoffmann R, Thermann H and Wippermann BW: Rupture of the ankle ligaments. Int Orthop. 15:245–249. 1991. View Article : Google Scholar : PubMed/NCBI
25	Stiell IG, Greenberg GH, McKnight RD, Nair RC, McDowell I, Reardon M, Stewart JP and Maloney J: Decision rules for the use of radiography in acute ankle injuries. Refinement and prospective validation. JAMA. 269:1127–1132. 1993. View Article : Google Scholar : PubMed/NCBI
26	Stiell IG, McKnight RD, Greenberg GH, McDowell I, Nair RC, Wells GA, Johns C and Worthington JR: Implementation of the Ottawa ankle rules. JAMA. 271:827–832. 1994. View Article : Google Scholar : PubMed/NCBI
27	Karpas A, Hennes H and Walsh-Kelly CM: Utilization of the Ottawa ankle rules by nurses in a pediatric emergency department. Acad Emerg Med. 9:130–133. 2002. View Article : Google Scholar : PubMed/NCBI